Synergistic Effect of the Combined Action of Targeted and Photodynamic Therapy on HER2-Positive Breast Cancer

被引:0
|
作者
I. V. Balalaeva
L. V. Krylova
M. A. Karpova
A. A. Shulga
E. V. Konovalova
E. L. Guryev
S. M. Deyev
机构
[1] Lobachevsky State University of Nizhny Novgorod,
[2] Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry,undefined
[3] Russian Academy of Sciences,undefined
[4] Sechenov First Moscow State Medical University,undefined
来源
关键词
targeted therapy; recombinant anticancer toxin; DARPin-LoPE; photodynamic therapy; photodithazine; breast cancer; HER2 receptor;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:330 / 333
页数:3
相关论文
共 50 条
  • [31] Adjuvant trastuzurnab therapy for HER2-Positive breast cancer
    Jahanzeb, Mohammad
    CLINICAL BREAST CANCER, 2008, 8 (04) : 324 - 333
  • [32] Trastuzumab therapy in HER2-positive, metastatic breast cancer
    Smith, A. D.
    Guilbert, K.
    Lister, D.
    Streilein, S.
    Bourrier, V. C.
    Lozar, B.
    Navaratnam, S.
    Harding, G. A.
    Pitz, M. W.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [33] Systemic therapy for metastatic HER2-positive breast cancer
    Bredin, Philip
    Walshe, Janice M.
    Denduluri, Neelima
    SEMINARS IN ONCOLOGY, 2020, 47 (05) : 259 - 269
  • [34] Mechanisms of Resistance to HER2-Targeted Therapies in HER2-positive Breast Cancer
    Veeraraghavan, Jamunarani
    Liao, Fu-Tien
    Qin, Lanfang
    Gordon, Tia
    Raghavan, Alekya
    Sabotta, Caroline
    Kaplan, Rachel
    Gutierrez, Carolina
    Osborne, C. Kent
    Rimawi, Mothaffar F.
    Schiff, Rachel
    CANCER RESEARCH, 2024, 84 (03)
  • [35] Novel HER2-targeted therapies for HER2-positive metastatic breast cancer
    Kunte, Siddharth
    Abraham, Jame
    Montero, Alberto J.
    CANCER, 2020, 126 (19) : 4278 - 4288
  • [36] HER2DX: Advances in targeted treatment of HER2-positive breast cancer
    Andujar, Juan M. Cejalvo
    REVISTA DE SENOLOGIA Y PATOLOGIA MAMARIA, 2024, 37 (03):
  • [37] Molecular Basis of HER2-Targeted Therapy for HER2-Positive Colorectal Cancer
    Yoshikawa, Ayumu
    Nakamura, Yoshiaki
    CANCERS, 2023, 15 (01)
  • [38] Targeted therapy for HER2 positive breast cancer
    Jason A Incorvati
    Shilpan Shah
    Ying Mu
    Janice Lu
    Journal of Hematology & Oncology, 6
  • [39] Targeted therapy for HER2 positive breast cancer
    Incorvati, Jason A.
    Shah, Shilpan
    Mu, Ying
    Lu, Janice
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2013, 6
  • [40] MNX1 promotes tumor sensitivity to HER2-targeted therapy in HER2-positive breast cancer
    Chi, Wei-Ru
    Xiu, Bingqiu
    Xiong, Min
    Li, Pei
    Zhang, Qi
    Li, Lun
    Hou, Jianjing
    Zhou, Xujie
    Sang, Yuting
    Chen, Ming
    Zhang, Liyi
    Xue, Jingyan
    Chi, Yayun
    Wu, Jiong
    CANCER RESEARCH, 2023, 83 (05)